Obesity and changing lifestyle have led to an increase in the occurrence of diabetes among the young and old in UK. This report highlights the market trends, epidemiology demographical breakup, diagnosis and treatment and the key players in the UK diabetes market. Read full report @ http://www.imarcgroup.com/UK-diabetes-market

1. Imarc
www.imarcgroup.com
Consulting Services
Copyright © 2016 International Market Analysis Research & Consulting (IMARC). All Rights Reserved
UK Diabetes Market
Report: 2016 - 2020

2. The International Market Analysis Research and Consulting Group is a leading advisor on management
strategy and market research worldwide. We partner with clients in all sectors and regions to identify
their highest-value opportunities, address their most critical challenges, and transform their
businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food
and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.
Report DescriptionAbout IMARC Group
Imarc
www.imarcgroup.com

3. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
UK Diabetes Market Report 2016 – Industry Analysis, Demographics, Diagnosis and Treatment
and Forecasts
MARC’s new report “UK Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into
the UK diabetes market. The report provides both current and future trends in the prevalence, demographical
breakup, diagnosis and treatment of diabetes in UK. The research study serves as an exceptional tool to
understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the
UK diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing
strategists and all those who are planning to foray into the UK diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:
Focus of the Analysis:
• Historical, current and future prevalence of diabetes in UK
• Historical, current and future prevalence of type-1 and type-2 diabetes in UK
• Historical, current and future prevalence of diabetes in the urban and rural regions in UK
• Historical, current and future prevalence of diabetes among males and females in UK
• Historical, current and future prevalence of diabetes among various age groups in UK
• Historical, current and future diagnosis rates for diabetes in UK
• Historical, current and future drug treatment rates for diabetes in UK

4. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
Comprehensive situation analysis of the UK Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
• Performance of the Oral Antidiabetics market in Uk
• Performance of key classes
• Performance of key players
• Market outlook
Comprehensive situation analysis of the UK Insulin market and its dynamics:
Focus of the Analysis:
• Performance of the Insulin market in Uk
• Performance of key classes
• Performance of key players
• Market outlook

5. Uk Diabetes Market
Imarc
www.imarcgroup.com

6. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
Table of Contents
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications
4 Key Factors Driving the Diabetes Market in UK
5 UK Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
6 UK Diabetes Market
6.1 Historical Market Trends
6.2 Market Outlook
6.3 Market Breakup by Segment
6.4 UK Oral Antidiabetics Market
6.4.1 Historical Market Trends
6.4.2 Market Breakup by Class

7. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook
6.5 UK Insulin Market
6.5.1 Historical Market Trends
6.5.2 Market Breakup by Class
6.5.3 Market Shares of Key Players
6.5.4 Market Outlook
List of Figures
Figure 3 1: The impact of Diabetes in the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035
Figure 4 2: UK: Overweight & Obese Population* (in Million), 2010, 2015 & 2020
Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 4 4: UK: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
Figure 4 5: UK: Diabetes Prevalence By Age Groups, (in %)
Figure 5 1: UK: Total Number of Diabetes Patients* (in 000), 2008-2015
Figure 5 2: UK: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020
Figure 5 3: UK (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015
Figure 5 4: UK (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020
Figure 5 5: UK (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 -2015
Figure 5 6: UK (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020

8. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
Figure 5 7: UK (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015
Figure 5 8: UK (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 9: UK: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 - 2015
Figure 5 10: UK: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 - 2020
Figure 6 1: UK: Diabetes Drugs Market (in Million US$), 2008 - 2015
Figure 6 2: UK: Diabetes Drug Market Forecast (in Million US$), 2016 - 2020
Figure 6 3: UK: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008- 2015
Figure 6 4: UK: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016 - 2020
Figure 6 5: UK: Oral Antidiabetics Market: (in Million US$), 2008 - 2015
Figure 6 6: UK: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008 & 2015
Figure 6 7: UK: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 6 8: UK: Oral Antidiabetics Market: (in Million US$), 2016 - 2020
Figure 6 9: UK: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2020
Figure 6 10: UK: Insulin Market, (in Million US$), 2008 - 2015
Figure 6 11: UK: Breakup of Insulin Market by Class (in %)
Figure 6 12: UK: Insulin Market: Sales Share of Key Players (in %)
Figure 6 13: UK: Insulin Market Forecast (in Million US$), 2016 - 2020

9. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
List of Tables
Table 3 1: Diagnosis of Diabetes
Table 4 1: Global: Diabetes Population Breakup by Country (in 000’s), 2015 & 2035
Table 4 2: UK: Overweight &Obesity Statistics, 2010, 2015 & 2020
Table 4 3: UK: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
Table 5 1: UK: Total Prevalence & Number of Diabetes Patients*, 2008, 2015 & 2020
Table 5 2: UK (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 3: UK (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 4: UK (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions),
2008, 2015 & 2020

10. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa:
Email:ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/UK-diabetes-market

11. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
© 2016 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

12. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +91-120-4155099
E-MAIL: sales@imarcgroup.com
http://www.imarcgroup.com
Contact Us